Cargando…
Seroresponse to Third Doses of SARS-CoV-2 Vaccine Among Patients Receiving Maintenance Dialysis
Autores principales: | Hsu, Caroline M., Lacson, Eduardo K., Manley, Harold J., Aweh, Gideon N., Miskulin, Dana, Johnson, Doug, Weiner, Daniel E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the National Kidney Foundation, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972976/ https://www.ncbi.nlm.nih.gov/pubmed/35378208 http://dx.doi.org/10.1053/j.ajkd.2022.03.002 |
Ejemplares similares
-
Seroresponse to SARS-CoV-2 Vaccines Among Maintenance Dialysis Patients
por: Hsu, Caroline M., et al.
Publicado: (2022) -
SARS-CoV-2 Vaccine Effectiveness and Breakthrough Infections Among Patients Receiving Maintenance Dialysis
por: Manley, Harold J., et al.
Publicado: (2023) -
Serial SARS-CoV-2 Antibody Titers in Vaccinated Dialysis Patients: Prevalence of Unrecognized Infection and Duration of Seroresponse
por: Hsu, Caroline M., et al.
Publicado: (2023) -
COVID-19 Among US Dialysis Patients: Risk Factors and Outcomes From a National Dialysis Provider
por: Hsu, Caroline M., et al.
Publicado: (2021) -
Prolonged Live SARS-CoV-2 Shedding in a Maintenance Dialysis Patient
por: Lacson, Eduardo, et al.
Publicado: (2020)